PALISADE BIO, INC. (PALI)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 29, 2025 | CORRESP | Neutral/Informational | High | Palisade Bio, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, originally filed on September 29, 202… | Read Filing EDGAR |
| Sep. 29, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from Ladenburg Thalmann & Co. Inc. indicates their concurrence with Palisade Bio, Inc.'s request to accelerate the effective date of their registration statemen… | Read Filing EDGAR |
| Sep. 29, 2025 | CORRESP | Neutral/Informational | High | Palisade Bio, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, which was filed on September 29, 2025… | Read Filing EDGAR |
| Sep. 29, 2025 | CORRESP | Neutral/Informational | Low | The correspondence from Palisade Bio, Inc. addresses comments from the SEC regarding their Draft Registration Statement on Form S-1. The SEC had raised concerns about the exercise… | Read Filing EDGAR |
| Sep. 29, 2025 | CORRESP | Positive/Resolved | Moderate | The correspondence from Ladenburg Thalmann & Co. Inc. indicates their support for Palisade Bio, Inc.'s request to accelerate the effective date of their registration statement to … | Read Filing EDGAR |
| Aug. 26, 2025 | CORRESP | Neutral/Informational | Moderate | Palisade Bio, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, which was filed on August 15, 2025. They are seeking to hav… | Read Filing EDGAR |
| Aug. 21, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Palisade Bio, Inc. that they will not review the company's registration statement filed on August 15, 2025. The SEC has reminded the company of its res… | Read Filing EDGAR |
| Jul. 14, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has conducted a limited review of Palisade Bio, Inc.'s draft registration statement on Form S-1 submitted on July 3, 2025. They have raised a comment regarding the Series … | Read Filing EDGAR |